Roivant enters new phase of corporate journey with 3+ launches, 4+ NDA/BLA filings, 8+ pivotal and 3+ proof-of-concept study readouts expected ...

As the U.S. economy continues to face sticky inflation and softening job growth, the Federal Reserve cut rates for the third time this year. Meanwhile, tariffs, supply-chain pressures and uneven ...

What do employers need to consider to effectively balance tech and the human touch. Ayaskant Sarangi, Mphasis’ Chief HR ...

Trump accounts are new government investment accounts for children under 18, launching in 2026 with $1,000 federal deposits ...

This funding was awarded through the ALS Association's Hoffman ALS Clinical Trial Awards Program, which aims to accelerate the development of new ALS treatments ARLINGTON, Va., Dec. 4, 2025 ...

Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific antibody, and multiple ...

Cynata is preparing for two trial readouts in 2026 in knee osteoarthritis and acute graft-versus-host disease.

Most people spend countless hours planning their retirement before the big day finally arrives. After all, it usually takes a ...

Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company developing precision medicines that modulate regulatory T cells (Tregs) to restore immune balance, today announced dosing of the ...

Roche shares rose after the Swiss pharmaceutical company said an experimental pill for breast cancer showed positive results in a large late-stage trial. The drugmaker said Tuesday that the trial ...

As some drivers have learned the hard way, Hampton Roads is ahead of the curve in using technology to address speeding. But — as positive as the public safety benefits of that effort might be — ...